Glissmann, head of asset allocation research at Goldman Sachs, on the outperformance of European and Chinese stocks over the ...

There's no question the financial services industry is home to some of the world's most dominant businesses. One such company ...

Expectations of a banner year in dealmaking have not yet materialized due to worries about inflation and uncertainties over U ...

Investors might be surprised to learn that in the past five years, shares of Goldman Sachs (NYSE: GS) have soared 186%.

Super Micro may also face margin pressures as it focuses on share gains. Customer concentration risks and prior financial ...

Couchbase (NASDAQ:BASE – Free Report) had its target price trimmed by The Goldman Sachs Group from $18.00 to $16.00 in a ...

Relay Therapeutics (NASDAQ:RLAY – Free Report) had its price objective lowered by The Goldman Sachs Group from $20.00 to ...

This gold miner could be a top pick for investors wanting exposure to this side of the market. The post Goldman Sachs says ...

Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price objective hoisted by The Goldman Sachs Group from $13.00 to ...

CrowdStrike (NASDAQ:CRWD – Free Report) had its price objective raised by JPMorgan Chase & Co. from $418.00 to $450.00 in a ...

Goldman Sachs strategists listed their “rising stars.” These are Russell 1000 (NYSEARCA:IWB) stocks with the largest increase ...

Goldman Sachs analyst Eric Cha upgraded KT Corp. (KT) to Buy from Neutral with a price target of KRW 59,000, up from KRW 49,000, implying 24% ...